ad image

Celiac Disease

1 / 1
Precigen ActoBio
IND Approval

ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten

Precigen ActoBio

PR-M09-19-NI-006Sep 04, 2019
Amgen
Celiac Disease

Amgen and Provention Bio Announce Co-Development Collaboration In Celiac Disease

Amgen

PR-M11-18-NI-018Nov 06, 2018
1 / 1